deltatrials
Completed PHASE4 INTERVENTIONAL 2-arm NCT00815100

Effects of the Ivabradine on Reduction of Inflammatory Markers in Patients With Acute Coronary Syndrome

Randomised, Double-blind, Placebo-controlled Trial of IVabradine in Patients With Acute Coronary Syndrome: Effects of the If Current Inhibitor Ivabradine or rEduction of Inflammation maRkers in Patients With Acute Coronary Syndrome

Sponsor: Hospital Universitario de Canarias

Conditions Acute Coronary Syndromes
Interventions Ivabradine Placebo
Updated 7 times since 2017 Last updated: Aug 7, 2020 Started: Apr 30, 2009 Primary completion: Apr 30, 2011 Completion: Sep 7, 2011
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Acute Coronary Syndromes and is currently completed. Hospital Universitario de Canarias leads this study, which shows 7 recorded versions since 2009 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotUnknown Status~Jun 2018 – ~Sep 2020 · 27 months · monthly snapshotUnknown Status~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 9 months · monthly snapshotCompleted

Change History

7 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE4

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE4

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  5. Sep 2020 — Jan 2021 [monthly]

    Completed PHASE4

    Status: Unknown Status → Completed

▶ Show 2 earlier versions

  1. Jun 2018 — Sep 2020 [monthly]

    Unknown Status PHASE4

  2. Jan 2017 — Jun 2018 [monthly]

    Unknown Status PHASE4

    First recorded

Apr 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Hospital Universitario de Canarias
Data source: Hospital Universitario de Canarias

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations